Main Menu

Pioneering technology

Novosound adds staff after funding boost for sensors

Richard Cooper (founder and CEO) with Dave Hughes of Novosound

Breaking new ground: Richard Cooper with Dave Hughes


 

A firm at the cutting edge of ultrasound technology is hiring skilled tech staff after receiving further funding support from Scottish Enterprise.

Novosound said it will use the £1 million grant from Scottish Enterprise to rapidly scale up the company’s R&D activity and recruit 17 workers with skills in STEM disciplines bringing staff numbers to over 30.

The company, which is based at Biocity, the biotech incubator located on the M8 near Glasgow, was the first spin-out from the University of the West of Scotland, raising £1.5m at its seed investment round in April 2018.

The business recently moved to a 2,400 sq ft laboratory and manufacturing facility at BioCity to allow all manufacturing to be undertaken on-site and by the company’s specialist staff using a newly installed £350,000 piece of equipment which creates the core sensor material.

Novosound was founded by Dr Dave Hughes and Richard Cooper and has revolutionised ultrasound technology, which had remained largely unchanged for 40 years, by replacing conventional sensor materials with a flexible piezoelectric thin-film. 

Dr Hughes said: “The global opportunity for Novosound is enormous with the ultrasonic market now valued at $45 billion and growing at over 10% every year and this funding will allow us to scale up and significantly accelerate our R&D and production activity. 

“As well as bolstering our existing R&D team, it allows us to create seventeen new highly skilled jobs for technical people with STEM skills which we are looking to fill in the coming months. Currently, our R&D team is 50% female and we hope to build on this with the new recruits.”




Medical ultrasound technology was pioneered in Glasgow 60 years ago by Professor Ian Donald who developed the technology for use in medical diagnostics utilising industrial ultrasound equipment from near-by Babcock-Wilcox in Renfrew (now Doosan Babcock). 

Dr Hughes added: “It is exciting that we are based just a few miles away from where Professor Ian Donald pioneered diagnostic ultrasound technology in the 1950s.  At the time, he created truly revolutionary technology and our team is motivated to build on Scotland’s history of invention in medical imaging and ultrasound.

“Whilst ultrasound is best known for its use in hospitals around the world, it is also the go-to tool for non-destructive testing in numerous sectors including oil & gas, aerospace, and nuclear.  For example, the current, and dated, sensor technology can only operate at low temperatures and therefore, the oil & gas industry alone incurs costs of billions of dollars every year because they have to shut down refineries to allow the testing to be carried out.  

“Our technology works efficiently at high temperatures thus removing the need to shut down at all, saving those lost billions of dollars. By applying our technology in different ways, similar cost-savings can be found in aerospace and renewables.

“This grant also enables us to create a medical sensors team at Novosound. NHS England alone carries out around nine million diagnostic ultrasound scans every year and so the prospect within healthcare is exciting too.  Here, our tech can create MRI resolution images but without the cost. This is game changing.”




Business Secretary Jamie Hepburn said:  “We want Scotland to be a leader in the technological and social innovations of the future, to harness that innovation to improve lives for the better and to export our solutions to the rest of the world. That is why we have set an ambitious target of doubling business expenditure on research and development from £875million in 2015 to £1.7billion by 2025. 

“I look forward to Novosound developing its business further in the coming months and years as the company grows and becomes a leading developer in hi-tech sensors.”

David Smith, Director of National Opportunities, Scottish Enterprise, said: “Novosound’s innovative work in developing ultrasound sensing technology for applications in the biomedical and industrial markets is really exciting.  

“Providing support to entrepreneurially-minded companies, such as Novosound, to allow them to achieve their growth ambitions is a key priority for Scottish Enterprise as part of our recently published Strategic Framework.  Scottish Enterprise looks forward to continuing to work in partnership with Novosound as the company develops its global presence.” 

Early stage investors in Novosound include: Par Equity, Kelvin Capital, Gabriel investment syndicate, the Scottish Investment Bank, the EOS Technology Investment Syndicate and Investing Women.

 



Leave a Reply

Your email address will not be published. Required fields are marked as *

This site uses Akismet to reduce spam. Learn how your comment data is processed.